Low BMI and FSH Levels: Clinical Impact and Management
Low BMI (particularly <18.5 kg/m²) suppresses FSH and LH through functional hypothalamic amenorrhea (FHA), where energy deficit disrupts GnRH pulsatility, preferentially reducing LH while FSH remains relatively preserved, and weight restoration to BMI ≥18.5 kg/m² is the primary therapeutic intervention before considering ovulation induction. 1
Mechanism of Hormonal Suppression in Low BMI
- Energy deficit from low body weight suppresses the hypothalamic-pituitary-gonadal axis, leading to decreased GnRH pulsatility that creates a characteristic hormonal pattern 1
- The LH to FSH ratio typically falls below 1 in approximately 82% of FHA patients, which serves as a useful diagnostic marker 1
- This is a central (hypothalamic) problem, not an ovarian dysfunction—the ovaries remain functional, as proven by restoration of ovulation with pulsatile GnRH administration 1
Associated Hormonal Changes Beyond FSH/LH
When energy availability drops below 30 kcal/kg fat-free mass per day, multiple hormonal alterations occur 1:
- Decreased estradiol and progesterone (the primary mechanism of menstrual dysfunction) 1
- Decreased leptin with increased ghrelin and cortisol 1
- Decreased insulin and IGF-1 1
- Decreased thyroid hormones (T3, T4) 1
Critical Diagnostic Distinctions
Do not confuse FHA with other conditions that affect FSH:
- PCOS shows the opposite pattern: LH:FSH ratio >2 (vs. <1 in FHA), with higher testosterone and lower SHBG than FHA patients 1
- Primary ovarian insufficiency and menopause show elevated FSH and LH due to ovarian failure, not suppression 1
- FHA patients lack insulin resistance, which is common in PCOS 1
Clinical Assessment of Low Energy Availability
BMI <17.5 kg/m² or <85% of expected body weight indicates overt signs of low energy availability 2
For adolescents, use BMI percentile method rather than absolute BMI cut-offs, examining weight in relation to the 50th BMI percentile 2
Additional markers of low energy availability include 2:
- Low triiodothyronine (T3)
- Reduced resting metabolic rate (measured RMR/predicted RMR <0.90)
- Recent weight loss or inadequate dietary intake
Management Recommendations
Primary Intervention: Weight Restoration
The Endocrine Society recommends BMI should reach ≥18.5 kg/m² before ovulation induction is offered 1
- Weight restoration is the primary therapeutic intervention for FHA 1
- For breast cancer patients with low BMI (<20) or who have lost ≥10% of usual weight in <6 months, there is increased risk of complications including bone fracture risk 2
- A healthy weight (BMI 20-24.9) must be encouraged 2
Nutritional Support
Adequate dietary protein intake of 1.2-1.5 g/kg/day should be ensured to prevent sarcopenic obesity and maintain muscle mass 2
- Avoid the misinformed tendency to become vegetarian or vegan during treatment, as this limits high-quality dietary protein intake and leads to malnutrition affecting long-term prognosis 2
- Nutritional assessment should be performed immediately after diagnosis and periodically during disease course 2
- Patients should be referred to a registered sports dietitian for comprehensive nutrition assessment 2
Pharmacologic Considerations
Clomiphene citrate is not recommended as first-line treatment for FHA due to uncertain efficacy and lack of randomized trials 1
- Address the underlying energy deficit first before considering ovulation induction 1
- Pulsatile GnRH administration can restore ovulation, proving ovarian functionality is preserved 1
Common Pitfalls to Avoid
- Do not assume weight stability indicates adequate energy availability—athletes in negative energy balance may experience suppression of physiological functions that restores energy balance and weight stability 2
- Do not use BMI alone to determine individual risk—body composition assessment is important as BMI does not account for muscle versus fat mass 2
- Do not overlook psychological stress and excessive exercise as contributing factors to FHA 1
- Do not misinterpret low-normal FSH as normal—in the context of amenorrhea and low BMI, this represents inappropriate suppression 1